33,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
17 °P sammeln
  • Broschiertes Buch

Cataracts, a major cause of serious visual impairment, have been treated since ancient times, beginning with rudimentary methods like couching. Surgical techniques evolved significantly over centuries. Non-surgical approaches to delay or prevent cataract formation have been increasingly a focus of research. The study in this book aims to summarize and critically evaluate the existing evidence on the efficacy and mechanisms of pirenoxine in the management of cataract and related ocular conditions. Pirenoxine exhibits multiple pharmacological actions that may delay cataractogenesis. While…mehr

Produktbeschreibung
Cataracts, a major cause of serious visual impairment, have been treated since ancient times, beginning with rudimentary methods like couching. Surgical techniques evolved significantly over centuries. Non-surgical approaches to delay or prevent cataract formation have been increasingly a focus of research. The study in this book aims to summarize and critically evaluate the existing evidence on the efficacy and mechanisms of pirenoxine in the management of cataract and related ocular conditions. Pirenoxine exhibits multiple pharmacological actions that may delay cataractogenesis. While promising, its global clinical use is limited due to the lack of large-scale randomized controlled trials. While Pirenoxine (Catalin) eye drops offer a pharmacological approach to delaying cataract progression via local ocular mechanisms, growing evidence suggests that systemic antioxidant supplementation may offer synergistic benefits.
Autorenporträt
Aamir Jalal Al-Mosawi is advisor doctor at the National Training and Development Center of the Iraqi Ministry of Health and Baghdad Medical City. He was the Head of Iraq Headquarter of Copernicus Scientists International Panel (2006-October, 2020). He is also member of the advisory council the International Association of Medical Colleges (IAMC).